EUROPE BONE DENSITOMETER MARKET 2022-2028

Europe Bone Densitometer Market 2022-2028

MARKET OUTLOOK

Triton Market Research’s report on the European bone densitometer market estimates that it would grow with a CAGR of 4.94% in the forecast years from 2022 to 2028. France, Italy, Germany, the United Kingdom, Spain, and Rest of Europe together form the market in this region.

In Italy, the number of patients of all ages affected by osteoporosis in the country increased significantly in the past decade. In 2021, the prevalence of osteoporosis among Italians was nearly 6.3%. 23.4% of women and 6.9% of men in the age group of 50 years and above were reported to be affected by the condition. The government of the country has recognized the need for preventing osteoporosis, fragility fractures, and falls as a priority, and is actively promoting best practices for the management of these conditions at a national level. All these factors are expected to drive the demand for bone densitometers in the country and aid the market’s growth.

More than 3 million people in Spain are said to have osteoporosis. The population of older people here is on the rise, which has led to an increase in the cases of osteoporotic fractures. A large number of people have also reported developing hip fractures. The healthcare system in the country is excellent, and boasts of highly-skilled healthcare professionals. Besides, Spain is also the fifth-largest healthcare market in Europe. It also has the highest number of pharmacies in the region. Most hospitals and pharmacies largely use bone densitometers to assess the risk of osteoporosis in the population. This is expected to drive the market growth in the coming years.

COMPETITIVE OUTLOOK

The primary contenders in the bone densitometer market include Swissray Global Healthcare Holding Ltd, GE Healthcare, BeamMed Ltd, Eurotec Systems Srl, Diagnostic Medical System Group, Osteometer MediTech Inc, Hologic Inc, and Trivitron Healthcare.